Tissue-engineered regeneration of the minipig TMJ condyle
Project Number5F32DE032896-02
Contact PI/Project LeaderBIELAJEW, BENJAMIN
Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
Project Summary
Approximately 10-25% of the population has degeneration of the temporomandibular joint (TMJ) condyle.
Cartilage does not heal itself, and there are no mid-stage interventions to prevent condylar degeneration which
can lead to life-threatening conditions such as changes to the airway. This proposal aims to improve translation
of tissue engineering strategies for TMJ condylar regeneration toward human use in the clinic via characterization
of the mandibular condyle of the Yucatan minipig, engineering neocartilage-bone implants with robust interfacial
properties, and in vivo studies using neocartilage-bone implants to regenerate osteochondral defects of the TMJ
condyle. Preliminary proteomics data show that spatial distributions of collagen types I and II can be achieved
using matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS), indicators of
fibrocartilage and hyaline articular cartilage, respectively. MALDI-IMS will serve as a powerful tool in a
characterization of the Yucatan minipig mandibular condyle, including the spatial distributions of collagen types
I, II, X, and XXVII. This characterization will provide gold standards for tissue-engineering approaches to treat
condylar defects. Preliminary ex vivo experiments indicate a high feasibility of creating osteochondral defects on
the TMJ condyle. Through these novel techniques, I will enhance tissue-engineering approaches for TMJ
condyle regeneration in three specific aims. In Specific Aim 1, many techniques, including MALDI-IMS, will be
used to characterize the TMJ condyle of the Yucatan minipig. This characterization will result in gold standard
values for engineered tissues. In Specific Aim 2, a novel tissue-engineering technique involving seeding of
mesenchymal stem cells into decellularized bone scaffolds, then combining with self-assembled neocartilage,
will be interrogated. This will result in the formation of neocartilage-bone implants with robust interfacial
properties for long term in vivo efficacy. Finally, in Specific Aim 3, neocartilage-bone implants will be used in a
large animal study, where they will regenerate defects of the Yucatan minipig TMJ condyle. Successful
completion of this proposal will enhance the translation of tissue engineering strategies for TMJ disorders toward
the FDA paradigm of clinical trials and human use in the clinic.
Public Health Relevance Statement
Project Narrative
Temporomandibular joint (TMJ) condyle degeneration affects approximately 50M Americans, and tissue-
engineered implants have the potential to regenerate osteochondral defects on the TMJ condyle. This proposal
will characterize the TMJ condyle of the Yucatan minipig, engineer neocartilage-bone implants with robust
interfacial properties, and regenerate osteochondral defects of the TMJ condyle in a large minipig model.
Successful completion of this proposal will enhance translation of neocartilage-bone implants toward human use
by showing safety and efficacy in an in vivo model, modeled after FDA preclinical definitive animal studies.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
046705849
UEI
MJC5FCYQTPE6
Project Start Date
11-April-2023
Project End Date
10-April-2026
Budget Start Date
11-April-2024
Budget End Date
10-April-2025
Project Funding Information for 2024
Total Funding
$75,084
Direct Costs
$75,084
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$75,084
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F32DE032896-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32DE032896-02
Patents
No Patents information available for 5F32DE032896-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32DE032896-02
Clinical Studies
No Clinical Studies information available for 5F32DE032896-02
News and More
Related News Releases
No news release information available for 5F32DE032896-02
History
No Historical information available for 5F32DE032896-02
Similar Projects
No Similar Projects information available for 5F32DE032896-02